Clover Health Investments Corp (CLOV) reported disappointing financial results for the third quarter of fiscal 2025. The company's earnings per share (EPS) came in at $-0.05, missing Wall Street's consensus estimate of $-0.03 by $0.02. Revenue matched expectations at $0.5 billion but failed to show growth.
The results highlight ongoing challenges for Clover, a physician enablement technology company focused on Medicare Advantage plans. Headquartered in Jersey City, New Jersey, Clover aims to improve healthcare access for seniors, particularly those who have historically faced barriers to affordable care. The firm employs 570 full-time staff and has been leveraging its Clover Assistant software platform to enhance clinical decision-making and health outcomes.
Clover will host an earnings conference call to discuss these results further and provide additional insights into its business performance. Investors are encouraged to review the full earnings release for context on the quarter's results and future outlook.
Looking ahead, Clover is set to announce its next earnings report on August 2, 2026, with an EPS estimate of $0.0068 and revenue expectation of $0.6 billion.